Immune System Diseases Recruiting Phase 1 Trials for Fludarabine (DB01073)

Also known as: Immune System Disease

IndicationStatusPhase
DBCOND0029769 (Immune System Diseases)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03602157Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCLTreatment
NCT03696784Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell LymphomaTreatment